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Abstract                                                                               
 Whatever their specialty (surgical, medical or both), intensive care 
units have to take care of patients due to life-threatening conditions as the 
result of one or even several organ failures. They register the highest 
mortality rates (Sheng WH, 2005), and the highest numbers of nosocomial 
infections (Mathieu LM, 2001). There have been numerous studies intended 
to evaluate the risk factors and the consequences of these infections in ICU 
(Intensive Care Unit) patients. However the analyses in most of these studies 
disregard the fact that there are additional competing events such as 
discharge or death. The study is retrospective. It is based on a total of 250 
patients of at least 16 years old and having spent at least 72 hours in ICU in 
the Timone University Hospital. Several risk factors were studied in two 
distinct competitive risk models. In the first model, we investigated the 
nosocomial infections risk factors with such a competing risk model as 
discharge (patients dead or living). The mortality risk factors were studied in 
the second model in which the patient being discharged faces the mortality 
competing risk. 46 patients developed at least one nosocomial episode, and 
65 died. The nosocomial infection objectified risk factors are: CVC (cause-
specific hazard ratio = 9.08; 95% CI 1.10 to 75.20), chronic renal failure 
(8.99; 95% CI 1.92 to 42.12) and tracheotomy (2.69; 95% CI 1.45 to 5.01). 
Cancer (2.69; 95% CI 1.48 to 4.89), transplant (7.30; 95% CI 1.83 to 29.19) 
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and the SOFA score (1.36; 95% CI 1.23 to 1.51) are the target factors for 
mortality risk.  Of all the documented scores in the present study the SOFA is 
the score with the highest predictive capacity as far as death risk is 
concerned. On the other hand, even if the nosocomial infection alters the 
event discharge, its impact on mortality is not completely established 
 
Keywords: Intensive care, risk factors, nosocomial Infections, ICU- 
mortality, competing risks models 
 
Introduction                                                                                                                     
Hospital acquired infection are a major and consequential health 
problem because of their frequency, their cost and their gravity (Sheng WH, 
2005), (Mathieu LM, 2001), (Ahmed HADDADI, 2013).    
 The efficiency’s control study of nosocomial infections led in the 
USA count around 2.1 million nosocomial events out of a total of 37.7 
million admissions in a year. According to the results of the same study the 
death rate due to nosocomial infections is 77, 000 (Ahmed HADDADI, 
2013), (Haley RW, 1985), (Archibald LK, 2007).    
Though the origins of the health care associated infections are 
similar, ICUs count prevalence rates two to five times higher than in other 
health care services. Indeed, according to (Digiovine B, 1999) 31.5% to 
82.4% of the patients may develop bacteraemia in ICU.   
These high rates can be mainly explained by the elaborateness of the 
pathologies, the therapeutic and/or diagnostic procedures, often invasive, that 
they require.     
The nosocomial event would be the result of the morbid interaction 
of pathogenic agents, healthcare and vulnerability of the patients. Thus, it 
may be due of a complex relationship between several factors (Wenzel R. P. 
Thompson, 1983).      
Amidst those factors, the studies (Sheng WH, 2005), (Ahmed 
HADDADI, 2013). (Archibald LK, 2007), (Wenzel R. P. Thompson, 1983), 
(Vincent JL, 2003), (Cevik MA, 2005), (Girou E, 1998), (Richards MJ, 
2000) quote the use of invasive devices, induced immunodepletion or 
secondary to acute pathology, the relatively advanced age of the patients, the 
associated chronic pathologies, antibiotherapy and multi-resistant bacteria. 
 The studies (Esen S, 2004), (Craven DE, 1988), (Ponce de León-
Rosales SP, 2000),  (Vincent JL, 2003), (Richards MJ, 1999) prove a 
significant association between nosocomial infection rates and the length of 
stay and, de facto, an increase of the cost. On the other hand, though it is 
difficult to establish a direct link between the nosocomial infection and the 
fatal issue of the patients in ICU it has been estimated that in France between 
10 000 and 20 000 deaths would be due to this cause.   
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Several studies documented the risk factors and consequences of 
nosocomial infection of patients in ICU. However, most of the studies did 
not take into account the fact that there may be other possible risks, 
competing with the event concerned – nosocomial infection – ((Ahmed 
HADDADI, 2013), (Gray RJ, 1988), (Andersen PK, 1985).  
 Indeed, once the patient has been admitted in ICU, his health can 
evolve towards one of these three outcomes: being infected with a 
nosocomial infection, a positive evolution leading to going home or to 
another healthcare service, a negative evolution, that is, death. His survival 
would depend on a competition of risks, one outcome preventing the other 
two outcomes from happening.       
The nosocomial infection has got two competing events: discharge or 
death competing with each other. Unlike logistic regression, the multi-states 
models are a very appropriate approach to take into account the competing 
events (Keiding N, 2001), (Klein JP, 2001).     
Indeed, they allow the modelling of the time-dependency of certain 
procedures (for instance intubation, tracheotomy, respiratory assistance 
etc...).  
Considering these three events (nosocomial infection, discharge or 
death) thanks to the analysis of two competing models (1 and 2) the aim of 
this paper is to identify the nosocomial infection risk factors on the one hand, 
and the causes of death on the other hand. 
 
Methodology                                                                                                                              
 This study is mono-centric and retrospective. The place of the study is 
Timone University Hospital's ICU, this hospital is known to be one the 
biggest of this area of France (south-eastern part of the country). Equipped 
with 1069 beds (793 for adults and 276 for children), it is Europe's third 
largest hospital. The ICU counts 9 beds.  
 The admission process – in the ICU- is the following one: the patient is 
recorded by the emergency unit, the patient is picked up by the Mobile 
Emergency Unit, the patient is transferred from an other care unit, the patient 
is transferred from another hospital.  
 The ethics committees agreed that no approval was needed, as the 
study was retrospective.  
 All information related to the identity of the patients will stay 
confidential.  
 The ICU-acquired infection diagnostics was based on bacteriological 
proofs.  
 The first day of infection is the day of the first positive collection 
knowing that only the first nosocomial episode was taken into account.  
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Using a standard form we systematically collected the following 
datas: age, gender, dates of ICU admission, end of the stay, the number of 
days spent at the ICU before the onset of the first nosocomial infection, the 
total number of days spent in hospital, the clinical settings (comorbidities, 
reason of hospitalization), origins of the patient, type of pathology, type of 
infection and pathogenic causal agents.  
We reported all the invasive procedures (intubation, tracheotomy, 
urinary catheter, central catheter, sedation), the duration of antibiotics before 
and after the nosocomial incident. 
The following scores were estimated for every included patient: the 
LOD (Logistic Organ Dysfunction) score, he SAPS II (Simplified Acute 
Physiology Score) and the SOFA (Sequential Organ Failure Assessment). 
 
Analysis of the nosocomial infection risk factors (Model 1)   
 After his admission (state 0), the patient evolves towards the two 
following states: Infected (state 1) or discharged (state 2) (dead or alive) 
(Figure 1).      
The impact of the two groups of risk factors was documented as far 
as the two competing models were concerned: the baseline risk factors 
(origin, male, antibiotic therapy at the admission, cancer, diabetes, 
transplant, hemopathy, infection at admission, chronic kidney disease, type 
of patient), and the time-dependent risk factors (death, intubation, antibiotic 
therapy, CVC (central venous catheter), arterial catheter, sedation, 
tracheotomy, urinary catheter, discharge).       
It should be noticed that apart from the age and the gravity scores 
values (LOD, SAPSII, SOFA), all risk factors were introduced in the model 
quoted before as binary variables. 
 
Analysis of the death risk factor (Model 2)      
In this model the evolution of the patient’s state proceeds with the 
following pattern: after his admission (state 0) the evolution is either 
unfavourable and the patient dies (state 1) or favourable and the patient is 
discharged (state 2) (figure 1).       
The impact of the same risk factors (baseline and time-dependent) as 
in Model 1 was documented. However, we will notice that the acquisition of 
a nosocomial infection was analysed on the basis of the time-dependent 
factor.       
Using the SAS software (v9.2.) two distinct Cox models were 
implemented. An analysis of the competing models was done for each model 
thanks to the cause-specific hazards (Andersen P, 1993), (Tai BC, 2001). 
 The first step consisted in calculating the cause-specific hazard ratio 
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for each risk factor with no preselecting. The global significance of the two 
models was tested using a multivariate analysis at level p= 5%.   
The second step consisted in improving the two models by taking 
out, step by step, the less significant variables as follows: we first selected 
the factors with a P-value of greater than 0.2 for the two events.   
We then evaluated the average of the P-values of these factors and 
took out the factor that obtained the highest average of P-values. We thus 
took out all the possible factors. We reiterated this process in applying a 
threshold of 0.1. 
This left us with a model where all the variables became significant, 
with a value P-values ≤5 % for at least one event.     
The selection of the model (Improved versus non improved) was 
based on the Akaike information criterion (A.I.C.): that is, the lower the AIC 
value, the better the model. Thanks to the correlation matrices of each Cox 
model, we could verify if there was any correlation between the different risk 
factors. The test of significance used is the chi-square.  
The cumulative incidence was determined for the most significant 
risk factors of each model.            
The cumulative incidence functions are adapted to illustrate an 
intuitive representation of the risk of occurrence of an event confronted by a 
competing event.  
They enable us to evaluate the probability for a healthy subject at 
time “s” to become ill at time “u” evaluated between “s” and “t”, knowing 
that between “t” and “u”, such a subject may be in one state or the other.  
On the other hand they enable us to check the probability for a 
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Results         
Out of a total of 565 patients hospitalized from January 1st 2011 to June 30th 
2012; we focused our study on 291 patients aged ≥ 18 with a ≥ 3 days stay. 
Among these eligible patients, 41 were excluded because of missing 
data. 46 (18.40%) of the 250 selected patients developed at least one 
nosocomial episode.    
The results corresponding to the gravity scores, the number and the 
baseline risk factors and time-dependent risk factors are described in Tables 
1, 2 and 3.  
However, we point out that 62.51% of the isolated bacteria were 
Gram-positive vs 37.49% of Gram-negative bacteria and that a resistant 







LOD 5.95 2.99 
SAPSII 46.51 15.99 
SOFA 5.78 2.51 
Age 60.23 14.49 










 76 30.4 
Antibiotics during admission 22 8.8 
Cancer 30 12.0 
Diabetic 44 17.6 
Transplant 7 2.8 
Hemopathy 6 2.4 
Infection at the admission 41 16.4 
Chronic renal failure 8 3.2 
Surgery patient 32 12.8 
Male gender 158 63.2 
Table 8: Frequencies and percentages of binary variables “baseline type” for the 250 
patients 
 
Variable Nombre Pourcentage 
Death 58 23.2 
Intubation 199 79.6 
Antibiotic therapy 184 73.6 
AC 229 91.6 
CVC 186 74.4 
Sedation 199 79.6 
UC 239 95.6 
discharge 185 74.0 
Tracheotomy 34 13.6 
(CVC: Central Venous Catheter, AC: Arterial Catheter, UC: Urinary Catheter) 
Table 9: Frequencies and percentages of time-dependent type variables for the 250 patients 
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Risk factors for nosocomial infection Model 1 
All the results of the Cause-specific hazard (calculated in multivariable 
analysis) of the baseline risk factors and of the time dependent risk factors 
are reported in Table 4.                                                                                                                
We notice that out of 21documented risk factors, only 6 are significant 
at the p =5% level.                   
The AIC (Akaike information criterion) of the multivariate model with 
all the risk factors is of 329 for the nosocomial infections and of 969 for the 
patients in discharge (dead or live). 





CI 95% P-value Cause-specific hazard ratio CI 95% P-value 
Age 0.98 [0.96 - 1.01] 0.14 0.99 [0.98 -1.00] 0.18 
Antibiothera
py 27700000 . . 0.45 [0.31- 0.66] <0.01 
Antibiotics at 
the admission 0.95 [0.27 -3.40] 0.94 0.61 [0.35 - 1.06] 0.08 
Cancer 0.64 [0.19 - 2.19] 0.48 1.12 [0.73 - 1.72] 0.61 
Arterial 
Catheter 0.72 [0.05 - 9.55] 0.80 1.19 [0.63 - 2.26] 0.59 
CVC 8.00 [0.31-206.09] 0.21 0.42 [0.26 -0.68] <0.01 
Diabetics 0.54 [0.21 -1.40] 0.20 1.14 [0.75 -1.73] 0.53 
Transplant 0.24 [0.02 -2.30] 0.21 1.70 [0.61 -4.77] 0.31 
Hemopathy 6.02 [0.90 -40.09] 0.06 0.58 [0.17 -1.94] 0.38 
Infection at 
the admission 0.16 [0.04 -0.73] 0.02 0.94 [0.63 -1.41] 0.78 
Chronic renal 
failure 54.68 [4.01-746.45] <0.01 0.35 [0.14 to 0.88] 0.03 
Intubation 10.65 [0.48 - 237.59] 0.14 0.72 [0.37 -1.39] 0.32 
LOD 0.95 [0.82 - 1.11] 0.52 1.00 [0.93 -1.07] 0.91 
Origin 1.22 [0.56- 2.64] 0.62 1.15 [0.80 -1.65] 0.45 
SAPS 0.99 [0.96 -1.02] 0.59 1.00 [0.99 -1.01] 0.91 
SOFA 1.08 [0.98 -1.19] 0.14 1.05 [0.98 -1.12] 0.16 
Male gender 1.81 [0.88 -3.70] 0.11 1.05 [0.76 -1.46] 0.77 
Urinary 
catheter 2060000 . . 0.30 [0.14- 0.65] 
<0.0
1 
Sedation 0.55 [0.09 -3.38] 0.52 0.87 [0.44 -1.71] 0.69 
Tracheotomy 2.04 [0.92 -4.52] 0.08 0.26 [0.15-0.46] <0.01 
Surgery 
patient 0.47 [0.16-1.37] 0.17 1.03 [0.64-1.65] 0.90 
Table 10: Nosocomial infection vs discharge: underlining the risk factors (multivariable 
analysis) 
 
The improvement of Model 1 was done according to the process 
described in our methodology. It left only 6 variables significant at level p 
=5% for at least one of the two states.      
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These are: antibiotic therapy, central venous catheter, and infection at 
time of admission, urinary catheter, chronic renal failure and tracheotomy.                                                         
All the results and pieces of information related to the CSHRs 
baseline risk factors and those of the time-dependent risk factors are reported 
in Table 6. 
 Nosocomial Infection Discharge (dead or alive) 




hazard ratio IC 95% 
P-
value 
Antibiotic therapy 11700000 . 0.99 0.48 [0.34 - 0.67] <0.01 












42.12] <0.01 0.36 
[0.15 - 
0.85] 0.02 
Urinary catheter 1620000 . 1.00 0.26 [0.13 - 0.53] <0.01 
Tracheotomy 2.69 [1.45 - 5.01] <0.01 0.28 
[0.17 - 
0.47] <0.01 
Table 6: Nosocomial infection vs discharge or death: identification of the significant risk 
factors at α=5%  (Improved model) 
 
The AIC results of the present model – Improved model – are lower 
than those of the initial model- The AIC value is 314 for the nosocomial 
infection and 952 for the patients in discharge (dead or alive). On the other 
hand, the correlation matrices do not show any relationship between the 
different factors. 
The cumulative impact functions are adapted to illustrate the results 
of an analysis of competing risk factors.      
 In the case of the present model (Improved Model 1), the cumulative 
incidence functions of the three most significant risk factors were established 
(Figure2). These are tracheotomy, CVC and chronic renal failure.                                                                                                            
Unlike the patients with no tracheotomy, the cumulative incidence function 
of nosocomial infection among tracheotomised patients is higher, very early, 
and quickly. It stabilizes after 20 days.     
 As far as the event is concerned (death or alive), the cumulative 
incidence function among patients with a tracheotomy is much lower than it 
is for the patients with no tracheotomy.                                                                                                                  
Furthermore, out of the patients affected with chronic renal failure, 
the cumulative incidence function for (death or discharge) is much lower 
than it is for patients who are not affected with that condition.    
 Concerning the cumulative incidence function, the patients affected 
with chronic renal failure show an increase per stage, which seems to 
stabilize after 5.8 days.  
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Figure 2: Cumulative incidence functions of (death or discharge) and nosocomial infection 
among tracheotomised patients versus non tracheotomised patients, among patients affected 
with chronic renal failure versus patients with no chronic renal failure and (CVC patients vs 
non CVC ones) 
 
Multivariate analysis of death risk factors for Model 2 – Table 10   
 It is pointed out that only 11 risk factors are significant at level p 
=5% for at least one of the events. The values of the AIC for model 2 
reporting all the risk factors are the following: 411 for the dead patients and 
975 for the patients in discharge.                                                             
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 Death Discharge 
Risk Factor Cause-specific hazard ratio CI 95% P-value 
Cause-specific 
hazard ratio CI 95% P-value 
Age 1.01 [0.98 -1.03] 0.68 0.99 [0.98 -1.00] 0.14 
Antibiotherapy 0.44 [0.21 - 0.92] 0.03 0.75 [0.47 - 1.21] 0.24 
Antibiotics at 
the admission 1.11 [0.41- 3.02] 0.84 0.52 [0.30 - 0.91] 0.02 
Cancer 3.11 [1.58 to 6.13] <0.01 0.74 [0.42 - 1.31] 0.30 
Arterial 
Catheter 0.26 [0.07 - 0.89] 0.03 1.50 [0.72 -3.12] 0.28 
CVC 0.56 [0.21 - 1.49] 0.25 0.45 [0.26 - 0.78] <0.01 
Diabetics 1.80 [0.90 - 3.60] 0.09 0.95 [0.60 - 1.50] 0.82 
Transplant 6.20 [1.18 - 32.50] 0.03 0.79 [0.23 - 2.74] 0.71 
Hemopathy 1.59 [0.20- 12.38] 0.66 0.72 [0.21- 2.48] 0.60 
Infection at the 
admission 0.75 [0.34 - 1.65] 0.48 0.76 [0.48- 1.20] 0.24 
Chronic renal 
failure 0.43 [0.10 - 1.91] 0.27 0.35 [0.12 -1.02] 0.05 
Intubation 0.43 [0.11 - 1.70] 0.23 1.01 [0.50 - 2.05] 0.98 
LOD 0.88 [0.77 - 1.01] 0.08 1.09 [1.01 -1.17] 0.02 
Origin 1.85 [0.94 - 3.65] 0.07 1.37 [0.94 - 2.00] 0.10 
SAPS 1.02 [1.00 - 1.05] 0.10 0.99 [0.97 -1.00] 0.05 
SOFA 1.43 [1.27 - 1.61] <0.01 0.89 [0.81- 0.98] 0.01 




174.53] 0.23 0.27 [0.12 - 0.64] <0.01 
Sedation 1.50 [0.37 - 6.05] 0.57 0.63 [0.30 - 1.30] 0.21 
Tracheotomy 0.03 [0.01 - 0.16] <0.01 0.34 [0.20 -0.57] <0.01 
Surgery patient 0.91 [0.36 - 2.28] 0.84 1.00 [0.62 - 1.62] 0.99 
Nosocomial 
Infection 0.31 [0.13 - 0.73] <0.01 0.43 [0.26 - 0.70] <0.01 
Table 10: Death versus discharge: highlighting the risk factors in a multivariable analysis 
 
The selection of variables of the second model operated in 
accordance with the statistic methodology described before leads to a model 
consisting in 10 significant variables at level p=5%: antibiotic therapy, CVC, 
cancer, transplant, LOD score, SAPS II score, SOFA score, urinary catheter, 
tracheotomy and nosocomial infection.                                                           
All the results and information related to the CSHRs of the baseline 
risk factors and of time-dependent risk factors, significant at level p =5% for 
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at least one of the two states  in the improved model obtained in a 
multivariable analysis are reported in Table 12. 










IC 95% P-value 
Antibiotic 
therapy 0.49 0.26 to 0.92 0.03 0.72 0.48 to 1.09 0.12 
Cancer 2.69 1.48 to 4.89 <0.01 0.79 0.45 to 1.38 0.40 
CVC 0.38 0.18 to 0.84 0.02 0.52 0.34 to 0.78 <0.01 
Transplant 7.30 1.83 to 29.19 <0.01 0.55 0.17 to 1.77 0.32 
LOD 0.89 0.77 to 1.01 0.08 1.08 1.00 to 1.16 0.04 
SAPS 1.02 1.00 to 1.04 0.10 0.98 0.97 to 1.00 0.01 
SOFA 1.36 1.23 to 1.51 <0.01 0.87 0.80 to 0.95 <0.01 
Urinary 
catheter 1.99 0.24 to 16.50 0.52 0.26 0.12 to 0.57 <0.01 
Tracheotomy 0.06 0.02 to 0.24 <0.01 0.36 0.22 to 0.57 <0.01 
Nosocomial 
Infection 0.31 0.13 to 0.70 <0.01 0.51 0.33 to 0.80 <0.01 
Table 12: Death vs discharge: highlighting of the significant risk factors at level α=5% for 
at least one of the two states obtained in a multivariable analysis. 
 
We noticed that the AIC of the improved Model 2 are lower than 
those of the initial Model 2: The AIC of the multivariable model counting 
only significant risk factors at level α =5% for at least one of the two states 
are 407 for dead patients and 976 for patients in discharge.   
 Moreover, the correlation matrices do not show any link between the 
factors, the improved model is thus of better quality. The cumulative 
incidence function -Figure 3, are about this three significant risk factors:  
tracheotomy, CVC and nosocomial infection.                                                                           
The charts show that among the patients with no tracheotomy, the 
CIF of the discharge event becomes higher, very early and quickly, and is 
much more significant than the death event. We also notice that the CIF of 
tracheotomised patients' death is less significant than that of the group of 
patients who did not have a tracheotomy.                                                                                                               
As far as the patients with a CVC are concerned, they have a death 
CIF that is much more significant than the group of patients who don't have 
one.                                                                                                                        
For the discharge event, the comparison is less obvious than in the 
CVC group.      
As for the patients with a nosocomial infection, the CIF of the event 
« discharge » is less significant than the CIF of the non-infected patients. 
The cumulative incidence function -Figure 3, are about this three significant 
risk factors:  tracheotomy, CVC and nosocomial infection.                                                                           
European Scientific Journal   February 2014  edition vol.10, No.6  ISSN: 1857 – 7881 (Print)  e - ISSN 1857- 7431 
325 
The charts show that among the patients with no tracheotomy, the 
CIF of the discharge event becomes higher, very early and quickly, and is 
much more significant than the death event. We also notice that the CIF of 
tracheotomised patients' death is less significant than that of the group of 
patients who did not have a tracheotomy.                                                                                                                
As far as the patients with a CVC are concerned, they have a death 
CIF that is much more significant than the group of patients who don't have 
one.                                                                                                                        
For the discharge event, the comparison is less obvious than in the 
CVC group.  
As for the patients with a nosocomial infection, the CIF of the event 
« discharge » is less significant than the CIF of the non-infected patients. 
 
Figure 3: CIF (Cumulative incidence function) of death and discharge of (tracheotomised 
patients vs non tracheotomised ones), of (CVC patients vs non CVC ones) and of 
(nosocomial patients vs non infected ones). 
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Discussion          
 Several studies documented the nosocomial infection risk factors and 
the death risk factors in ICU.        
 Among these factors, we point out: age, gender, a former stay in ICU, 
the length of stay, a pejorative Glasgow score (GCS), a high (APACHE) II 
score, a high SAPS II, respiratory failure, congestive heart failure, acute 
renal failure, dialysis, bronchoscopy, tracheotomy, re-intubation, the length 
of mechanical respiration, multidrug-resistant pathogen, CVC, bacteremia, 
enteral nutrition and corticosteroids, (Therneau T, 2000), (Apostolopoulou E, 
2003), (Sofianou DC, 2000), (Georges H, 2000), (Ibrahim EH, 2001), (Rello 
J, 2002), (Pawar M, 2003), (Erbay RH, 2004), (Boots RJ, 2005), (Myny D, 
2005), (Tejerina E, 2006),  (Gastmeier P, 2007).                                                                                                                                  
However, in most of these studies the effect of time-dependent 
factors was not taken into account. Schoenfeld and al, pointed out that it was 
more important to study the death event than the day of death. They suggest 
that mortality should be analyzed as a binary variable (30 days mortality) 
using logistic regression (Schoenfeld D, 2006). Thus these risk factors are 
often modeled with binary forms (present or absent). However, this binary 
consideration (present or absent) would be a bias according to (Van 
Walraven C, 2004).                                                                                                               
Also notice that in most of these papers, the competing events – 
nosocomial risk death event or discharge – are not taken into account or 
modeled in any other way. 
However, according to Hyun J Lim, and al, as soon as the patient 
acquires an event other than the one considered, the probability of knowing 
this event is de facto modified (Hyun J Lim, 2010). 
We also point out that Resche-Rigon and al, report that the event 
«discharge of the patients » should be taken into account as a competing risk 
to that of death in ICU (Resche-Rigon M, 2006).                                                                                                                                                  
In the present studies, we considered two multi-state models in order 
to precisely study the two important factors, that is the time-dependence risk 
factors and the competing risks.                                                                
 With the competing risk models, Kaplan-Meier’s estimate (Kaplan 
EL, 1958), (cumulative hazard function, {1 - SKM(t)}), which does account 
neither the informative censure -as for instance death while the patient is 
achieving remission (Kaplan EL, 1958), (Gaynor JJ, 2006), (Pepe MS, 
1993), seems to be inappropriate for the calculation of the cumulative 
incidence.  
This lack would be due to the fact that this method overestimates the 
probability of occurrence of the event of interest (Gaynor JJ, 2006), (Pepe 
MS, 1993), (Lin DY, 1997), (Southern DA, 2006), (Kalbfleisch JD, 2002). 
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The bias is even more important when the risk of competing events is high 
(Putter H, 2007). 
Thus, the methodology of analysis applied in our study is an 
alternative to the one of the cumulative hazard function.                                                                                                                                                                
Indeed, the Cox cause-specific hazard (Cox DR, 1972) and the cumulative 
incidence function (CIF) are appropriate approaches to analyze competing 
risks (Kalbfleisch JD, 2002). 
The Cause-specific hazard indicates the instantaneous rate of 
occurrence of a given event among the patients with no infection 
(Kalbfleisch JD, 2002), (Kalbfleisch JD, 1978). 
The CIF indicates the proportion of patients contracting an event at a 
definite time t- corresponding to the event.          
In Model 1, antibiotic therapy presents a high-risk report in favor of 
the appearance of a nosocomial event. However, it is not significant at all (p-
value = 0.99). This could be explained by the fact that all the patients with a 
nosocomial infection were under antibiotic therapy. Thus the model cannot 
be estimated (all the data being separated). 
Moreover, we notice that with antibiotic therapy the period of time 
before the event – death or discharge – is longer (CSHR=0.48).        
 We can draw the same conclusion as far as the « urinary catheter » 
factor is concerned (CSHR=0.26). However, we should moderate the fact 
that the presence of a urinary catheter may lengthen the period of time when 
the event « death » or « discharge » is due to take place. Indeed, almost 96% 
of the patients in study had been given a urinary catheter.                                                                                                                                                         
The infections at admission show a « protective » role against 
infection (CSHR=0.15). Indeed, this could be explained by the 
administration of antibiotics to infected patients when they are admitted in 
the service. The Martin Wolkewitz study dealing with the risk of nosocomial 
pneumonia agrees with our analysis. It gives a CSHR = 0.02 for pneumonia 
at the admission (Martin Wolkewitz, 2008).                                                                                                                                                  
In ICU, tracheotomy, whose therapeutic aim is often to provide a 
respiratory alternative, generates with its process a significant risk (partially 
or entirely) for nosocomial infection. Indeed, mechanical respiration, which 
is an integral part of the process, is related in the study (Martin Wolkewitz, 
2008) as the main risk factor for the development of nosocomial pneumonia, 
with an increase of the CSHR of 5,90. 
In the present studies, even if this is not as clear as in the improved 
model, tracheotomized patients seem to be the most vulnerable ones when 
confronted by nosocomial risk (CSHR=2.69).                                                                                                                                
We also notice that this slows down the event « death or discharge » 
significantly (CSHR=0,28). This can also be seen in Figure 2.  
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In Model 2, antibiotic therapy is reported as being a factor in 
postponing death (CSHR=0.49). On the other hand, one cannot draw any 
conclusion with regards to the event « discharge ». 
As for the urinary catheter, its presence leads inevitably to a longer 
stay and affects the « discharge » event (CSHR=0.26). This analysis is 
confirmed in study (Martin Wolkewitz, 2008). In addition, even if no 
conclusion can be drawn as far as its implication in the event « death » is 
concerned, it would be logical to think that patients with a urinary catheter 
have more risk to get a nosocomial infection. The natural process being an 
entry, it is followed by colonization and infection.                                                                                                                                                                    
On the other hand the Central venous catheter seems to have a severe 
impact on death risk (CSHR=0.38) and also on a smaller scale on the event 
« discharge » (CSHR=0.42). It significantly extends the length of stay. This 
strengthens its role of nosocomial infection provider, reported in model 1 
(CSHR=9.08) p-value =0.04. 
As far as tracheotomy is concerned, it appears to be an important 
factor in postponing death (CSHR=0.06).  The same conclusions were 
reported by Combes A and al (Combes A, 2007).  
The curves for the event « death » in the group of tracheotomized 
patients clearly show this tendency.                                                                                                                                          
We can also conclude that on the same model for the CVC factor, 
tracheotomy postpones death but lengthens the stay. 
On the other hand, with a (CSHR=2.69), the patients with cancer 
seem to be more at risk to die. However, we should keep in mind that a 
combination of variables must be referred to (confounding factors) when we 
calculate the cancer factor (Staudinger T, 2000). 
As far as the gravity scores are concerned, though the LOD and 
SAPS II scores are significant – for the discharge event – an increase of one 
score unit « SAPS II » does not mean that there will be an impact on the 
« discharge » event (CSHR=0.98). 
On the contrary the SOFA score results show that an increase of one 
unit would increases the risk of death (CSHR=1.36) and affects at the same 
time the event « discharge » (CSHR=0.87).                                                                                                                                 
The results of the studies - done with several different methods of 
analysis – giving data on the impact on the nosocomial event- give rise to a 
great many conflicting views.                        
Thus, contrary to the results by Magnason S and al, (Magnason S, 
2008) and Gastmeier P and al, (Gastmeier P, 2005) which claim that the 
nosocomial event strongly increases the risk of death, those of the present 
paper reveal that a nosocomial infection can postpone the death event 
(CSHR=0.31) but lengthen the stay in hospital (CSHR=0.51).                                                                                               
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These results can also be observed on the diagram entitled « cumulative 
incidence function » (Figure 3).                                                                                                                                     
We also notice that after more than 10 days spent in the health care 
unit, a patient with no nosocomial infection has a 50% chance of survival.                                                                                                                                              
On the other hand, a patient contracting a nosocomial infection has less than 
15 % chances of survival. 
Several limits in the present studies should be mentioned such as the 
size of the study population, the fact that the study was monocentric and 
done retrospectively 
Conclusion         
 Nosocomial infection and mortality in ICU have multiple and 
complex risk factors. It would be a methodological mistake to reduce their 
analysis to the presence or the absence of infection.     
In the present study, the methodology of analysis seems to be the 
most adequate, for it considers every transitory step - or most of them- of the 
patient's state.                                                                                                                                                          
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